Drugs / MMC
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02973685 Comparator | Oct 2016 → Nov 2020 | hepatocellular carcinoma | Sun Yat-sen University | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MMC | “lipiodol mixed with chemotherapy drugs(EADM , lobaplatin, with or without MMC)” NCT02973685 ↗ |
| Route | Other | “Hepatic intra-arterial infusion with lipiodol mixed with chemotherapy drugs (EADM , lobaplatin, with or without MMC)” NCT02973685 ↗ |